Medical Monitoring Protocols


The development of general guidelines for DuPont C8 linked disease Medical Monitoring is mandated by Section 12.3.2 of the Class Action Settlement Agreement. The guidelines are important to our clients who are Class Members as defined in the Class Action. Each of those individuals who consumed water from one of the Class Action included water sources (contaminated by DuPont’s C8) now have the right to periodic medical testing, paid for by DuPont, to detect whether or not the Class Member may contract one or more of the DuPont C8/PFOA linked diseases.

The initial Medical Monitoring Protocols have been developed by the C-8 Medical Panel and are summarized in the final medical monitoring documents made available to the class on September 2, 2014. The comprehensive new medical monitoring program encompasses initial screening and diagnostic testing protocols including a free C8 blood test, a free in-person doctor visit, a free cholesterol test and other free tests and procedures to detect the early onset of the six diseases linked to C8 exposure. The Medical Panel has noted the potential need for future screening (monitoring) and related testing, the details of which are deferred to a future Medical Panel report.

In the meantime, the Medical Panel has released interim guidance clarifying the availability of follow-up tests for Class Members, such as when certain new warning symptoms develop. Those guidance documents can be found here:

Medical Panel Guidance (9/20/14)

Medical Panel Guidance (1/8/15)

Related to the need for future monitoring regarding DuPont C-8 linked diseases, the Medical Panel recommended that the Director of the Medical Monitoring Program be charged to develop a mechanism to gather relevant data on implementation and findings of the Medical Monitoring Protocol which will be used to evaluate whether to change the Medical Monitoring Program in the future.

The Medical Panel also created educational materials to help inform Class Members about the benefits and harms of screening (in addition to discussions that the Class Members should have with their regular physician or other health professional), which materials are being sent to class members and are available on the C8 Medical Monitoring Program website.

The following documents related to the Medical Monitoring Program are available below:

     Order Appointing Director of Medical Monitoring and Utilization of Brookmar, Inc. (11/20/12)

     Order Regarding May 1, 2014 Status hearing (5/19/14)

     Director's Interim Status Report (9/9/14)

     Director's Status Report (11/21/14)

     Plaintiffs Class Counsel's Response to Director's 11/21/14 Status Report (11/26/14)

     Director's Response (12/10/14)

     Director's Status Report (1/21/15)

     Director's Invoices (through 1/8/15)

     Director's Status Report (2/09/15)

     Director's Invoices (through 2/20/15)

     Director's Invoices (through 3/10/15)

     Director's Status Report (4-21-15)

     Director's Status Report (5-4-15)

     Director's Status Report (5-18-15)

     Director's Status Report (6-1-15)

     Director's Status Report (6-15-15)

     Director's Status Report (7-13-15)

     Total Services Approved for Payment (7-15-15)

     Weekly Summary Report (7-17-15)

     Director's Status Report (7-27-15)


To place your inquiry or question online, click here.

© Hill, Peterson, Carper, Bee & Deitzler, PLLC. All rights reserved .